Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.

Diabetes remains one of the nation’s most prevalent and dangerous chronic conditions, affecting nearly 15% of U.S. adults and causing more than 100,000 deaths each year. As a response, the landscape ...

DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With ...

The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes. It's the longest-lasting system on the market. The G7 ...

This morning Belgian startup Indigo Diabetes announced a €38 million ($44.6 million) Series B funding round. This round included contributions from new investors Fund+, Ackermans&van Haaren, Capricorn ...

The FDA has issued a class two device recall for Senseonics’ Eversense continuous glucose monitoring system. This posting follows a September notice from the company that alerted providers and ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes who used their CGM more than 270 days in 1 year had the largest decrease in HbA1c.

DexCom, Inc. DXCM announced that its DexCom ONE continuous glucose monitoring (CGM) system has been launched in France for people with diabetes. The latest CGM sensor from the company’s portfolio has ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Tandem t:slim X2 insulin pump can now integrate with ...

"Continuous Glucose Monitoring (CGM) Sensors Market" Size, Share, Growth Report 2023-2030 | | No. of pages: 103 Report which offers an in-depth analysis Grounded on Applications (Home Care, Hospital, ...